LIVER TRANSPLANT RECIPIENTS
Clinical trials for LIVER TRANSPLANT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT RECIPIENTS trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a booster shot and lowered immune drugs protect transplant patients from COVID?
Disease control CompletedThis study looked at whether giving an extra dose of the mRNA COVID-19 vaccine (Pfizer or Moderna) to kidney and liver transplant recipients could boost their antibody levels. Some participants also temporarily reduced their immunosuppressive medications to see if that helped the…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to predict organ rejection before it happens
Knowledge-focused CompletedThis study looked at 221 liver transplant patients to see if a simple lab test could predict who might reject their new organ. Researchers analyzed gene patterns in the patients' blood to find early warning signs. The goal was to better understand why some bodies accept a transpl…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC